Tirzepatide (Mounjaro) Weight Loss Specialist in Plano, TX

As part of a diet and exercise program, Mounjaro helps adults with type 2 diabetes control their blood glucose levels and lose weight. This dual agonist has been shown to have powerful effects on managing diabetes and obesity.
 
In beta and alpha cells of the pancreas, Mounjaro activates both GIP and GLP-1 receptors. In the presence of high blood glucose levels, beta cells release insulin, while in the presence of low blood glucose levels, alpha cells release glucagon. As a result of Mounjaro’s natural hormones, GIP and GLP-1, both beta and alpha cells are regulated.

The new medication tirzepatide (Mounjaro) is capable of helping people living with obesity and who are overweight. This injectable medication is FDA-approved for the treatment of Type 2 diabetes. People without diabetes are also prescribed it off-label for weight loss by some healthcare providers.

Diabetes patients can lose significant weight using tirzepatide combined with diet and exercise. Furthermore, it has been shown to cause weight loss even in people without diabetes.

By combining tirzepatide with diet and exercise, users can lose up to 20% of their body weight. It hasn’t been FDA-approved as a weight loss product yet, but it is expected to be soon. To help speed up a possible approval for weight loss, the FDA granted tirzepatide Fast Track designation.

Tizepatide reduces blood sugar, slows digestion, and signals your brain that you are full. Weight loss with this method may be one of many possible options; it may not be suitable for everyone, however. Your healthcare provider can help you decide which option is right for you.

Almost every aspect of health is compromised by excess weight, from reproductive function to memory and mood. Diabetes, heart disease, and certain types of cancer are debilitating, and deadly diseases associated with obesity. Many factors contribute to this, from mechanical stress caused by added weight to hormonal changes and changes in metabolism. Obesity negatively affects the quality of life and health of individuals, as well as the cost and quality of healthcare worldwide.

With Mounjaro, you can lose weight and maintain a healthy lifestyle, but it does not cause weight loss on its own. GLP-1 or dual GIP/GLP-1 drugs must be used in conjunction with other metabolic strategies if you want to sustain your weight loss. Among these tactics are changes to diet and exercise, as well as changes to lifestyle.

In addition to treating type 2 diabetes, tirzepatide, a once-weekly injectable drug, may also help obese people lose weight. Among obese or overweight people without type 2 diabetes, Mounjaro reduced weight by nearly 21 percent at its highest dose in clinical studies. 

Those with diabetes who are overweight and at high risk of heart disease may benefit from tirzepatide. As with all anti-obesity drugs, the official criteria for prescribing these drugs are the same for people without diabetes: a body mass index of 30 or higher, or a BMI of 27 or higher, as well as at least one obesity-related health problem.

Our team at Q-Day Walk-In Clinic, Primary Care will explain dosage, how to administer the medication, and when you should take it in conjunction with your metabolic reset when they determine that Mounjaro or another GLP-1 is the right fit for you. Weight loss can be treated with medications like Mounjaro, but that is only one part of the process. Physicians will work with patients to develop a comprehensive plan to lose weight, including realistic goals, diet, exercise, and medication as needed. To find out if Mounjaro tirzepatide injections for weight loss are right for you, contact Q-Day Walk-In Clinic, Primary Care.

Tirzepatide for weight loss is available at Q-Day Walk-In Clinic, Primary Care. For more information, contact us today or book an appointment online. We are conveniently located at 3560 E Park Blvd Plano, TX. We serve patients from Plano TX, Frisco TX, Garland TX, Carrollton TX, McKinney TX, Murphy TX, Wylie TX, and much more!